Home | MyCME | All CME | Blog | Psychlopedia
Multimedia CME
Multimedia | CME From JCP | JCP Supplement | CME From PCC

MultimediaAlthough levodopa is effective for treating Parkinson disease, physicians and patients face significant management challenges related to disease progression. Patients may develop fluctuations in motor symptoms and dyskinesias as well as nonmotor symptoms. Review this CME Brief Report activity to learn about new and emerging treatment options to manage patients’ symptoms. [top]

Parkinson Disease: Current Trends in Treatment and Unmet Needs

Parkinson Disease: Current and Emerging Treatment Strategies

Adolfo Ramirez-Zamora, MD

Improving the Diagnosis and Treatment of Adolescent Bipolar Disorder

Diagnosing Bipolar Disorder in Pediatric Patients

Kiki D. Chang, MD

Treating Bipolar Disorder in Adolescents

Robert L. Findling, MD, MBA

Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?

Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?

Christoph U. Correll, MD, and John Lauriello, MD

Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management

Cognitive Impairment in Major Depressive Disorder: A Case Discussion Illustrating Impact, Assessment, and Management

Larry Culpepper, MD, MPH (Chair); Raymond W. Lam, MD, FRCPC; and Roger S. McIntyre, MD, FRCPC

Strategies for Managing Patients With Depression Who Are Experiencing Cognitive Impairment

Larry Culpepper, MD, MPH

Impact of Cognitive Impairment on Functioning in Patients With Depression

Raymond W. Lam, MD, FRCPC

Available Tools for Assessing Cognitive Impairment in Major Depressive Disorder

Roger S. McIntyre, MD, FRCPC

What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options

Evidence-Based Strategies for Managing Tardive Dyskinesia

Joseph P. McEvoy, MD

What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options

J. Sloan Manning, MD, Joseph P. McEvoy, MD

Discussing the Risk of Tardive Dyskinesia With Patients and Screening for Signs

J. Sloan Manning, MD

Reconsidering Insomnia as a Disorder Rather Than Just a Symptom in Psychiatric Practice

Assessing and Treating Insomnia in Patients With Psychiatric Disorders, Part 1

Ruth M. Benca, MD, PhD (Chair), and Daniel J. Buysse, MD

Assessing and Treating Insomnia in Patients With Psychiatric Disorders, Part 2

Ruth M. Benca, MD, PhD (Chair), and Daniel J. Buysse, MD

Improving Remission Rates in Major Depressive Disorder: A Case-Based Approach

Improving Remission Rates in Major Depressive Disorder: A Case-Based Approach

Roger S. McIntyre, MD, FRCPC

Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?

Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?

Diana O. Perkins, MD, MPH

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Assessing Patients for Tardive Dyskinesia

John M. Kane, MD

Comparing Treatments for Tardive Dyskinesia

Leslie L. Citrome, MD, MPH

Epidemiology and Prevention of Tardive Dyskinesia

Christoph U. Correll, MD

Improving the Care and Management of Patients With Inadequate Response to Depression Treatment

Managing Medical Comorbidities in Patients With Depression to Improve Overall Prognosis

Michael E. Thase, MD

Identifying Patients Who Need a Change in Depression Treatment and Implementing That Change

George I. Papakostas, MD

Implementing Appropriate Treatment Strategies for Varying Types of Depression

Roger S. McIntyre, MD, FRCPC

​​​​